ATTO — Attovia Therapeutics
Median target
$42
calls from the last 12 months
Implied return
+84.8%
median target vs. price
Coverage
4 analysts · 4 calls
updated in the last 12 months
Consensus
4/0/0+4 net
Buy / Hold / Sell
Which analysts are behind ATTO's consensus?
See every current rating, price target and the analysts' track records for Attovia Therapeutics — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 4 analysts with calls on ATTO updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
ATTO elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-08-06 | Insiders | Frazier Life Sciences Xi, L.P. +210% owner | Insider purchase | 588.2K sh @ $17.00 | $10.0M |
| 2026-08-06 | Insiders | Goldman Sachs Group Inc +7 | Insider purchase | 500.0K sh @ $17.00 | $8.5M |
| 2026-08-06 | Insiders | Walsh ColinDirector | Insider purchase | 500.0K sh @ $17.00 | $8.5M |
| 2026-08-06 | Insiders | Walsh ColinDirector | Insider purchase | 500.0K sh @ $17.00 | $8.5M |
| 2026-08-06 | Insiders | Goldman Sachs Group Inc +7 | Insider purchase | 500.0K sh @ $17.00 | $8.5M |
| 2026-08-06 | Insiders | Redmile Group, Llc +210% owner | Insider purchase | 400.0K sh @ $17.00 | $6.8M |
| 2026-08-06 | Insiders | Venbio Global Strategic Fund I10% owner | Insider purchase | 382.4K sh @ $17.00 | $6.5M |
| 2026-08-06 | Insiders | Sanofi10% owner | Insider purchase | 300.0K sh @ $17.00 | $5.1M |
| 2026-08-06 | Insiders | Redmile Group, Llc +210% owner | Insider purchase | 200.0K sh @ $17.00 | $3.4M |
| 2026-08-05 | Insiders | Walsh ColinDirector | Insider purchase | 85.0K sh @ $21.00 | $1.8M |
More: insider activity · executive branch · trending